elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38325814-09E261D2-E1B6-453A-9930-388D4F253FC0
Q38325814-09E261D2-E1B6-453A-9930-388D4F253FC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38325814-09E261D2-E1B6-453A-9930-388D4F253FC0
Early investigational drugs targeting PPAR-α for the treatment of metabolic disease.
P2860
Q38325814-09E261D2-E1B6-453A-9930-388D4F253FC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38325814-09E261D2-E1B6-453A-9930-388D4F253FC0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5943224ad4204ab26880fab518dfde263d68f021
P2860
Peroxisome proliferator-activated receptor-alpha (PPARalpha): at the crossroads of obesity, diabetes and cardiovascular disease.